SCHEMBL574136

SCHEMBL574136

CCCC(C)CCCCO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.55
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 4/20 0.46
ALDH1A1 P00352 3/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ACE2 Q9BYF1 1/20 0.43
PRKD3 O94806 1/20 0.38
PRKCG P05129 1/20 0.38
PRKCB P05771 1/20 0.38
PRKCA P17252 1/20 0.38
PRKCH P24723 1/20 0.38
PRKCI P41743 1/20 0.38
PRKCE Q02156 1/20 0.38
PRKCQ Q04759 1/20 0.38
PRKCZ Q05513 1/20 0.38
PRKCD Q05655 1/20 0.38
PRKD1 Q15139 1/20 0.38
OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8420903 1.00 TSHR (0.55) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL9641955 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL1658068 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL9724988 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL3368771 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL345866 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL6158105 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL366532 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL7784084 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10
SCHEMBL6157071 0.97 TSHR (0.52) TSHRSMN1; SMN2LMNAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021124901-A1 PLASTICIZER FOR VINYL CHLORIDE RESINS, VINYL CHLORIDE RESIN COMPOSITION, AND MOLDED ARTICLE AND WIRING HARNESS EACH USING SAID VINYL CHLORIDE RESIN COMPOSITION DIC株式会社 2021-06-24 WO claimed
US-10773276-B2 Method for forming multilayer coating film NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) 2020-09-15 US claimed
EP-2377844-B1 Cyclohexane polycarboxylic acid derivatives containing adjuvants BASF SE (DE) 2017-10-18 EP claimed
US-9688838-B1 Diisononyl terephthalate plasticizer and its use as well as process for producing the same NAN YA PLASTICS CORPORATION (TW) 2017-06-27 US claimed
EP-3094613-A1 PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS Purdue Research Foundation, Inc. (US) 2016-11-23 EP claimed
EP-3027760-A1 PROCESS FOR THE BIOCONVERSION OF C3-C13 ALKANES TO C3-C 13 PRIMARY ALCOHOLS BASF SE (DE) 2016-06-08 EP claimed
WO-2015106045-A1 PROCESSES FOR THE SYNTHESIS OF CHIRAL 1-ALKANOLS PURDUE RESEARCH FOUNDATION (US) 2015-07-16 WO claimed
WO-2015014644-A1 PROCESS FOR THE BIOCONVERSION OF C3-C13 ALKANES TO C3-C 13 PRIMARY ALCOHOLS BASF SE (DE) 2015-02-05 WO claimed
EP-2377844-A2 Cyclohexane polycarboxylic acid derivatives containing adjuvants BASF SE (DE) 2011-10-19 EP claimed
US-7816553-B2 Cyclohexane polycarboxylic acid derivatives containing adjuvants BASF SE (DE) 2010-10-19 US claimed
EP-4638409-A1 PLASTICIZER COMPOUND BASF SE (DE) 2025-10-29 EP disclosed
US-12428364-B2 Method for processing benzene polycarboxylic acid esters and use of same to produce cyclohexane polycarboxylic acid esters BASF SE (DE) 2025-09-30 US disclosed
EP-3356459-B2 PLASTICIZER COMPOSITION CONTAINING POLYMERIC DICARBOXYLIC ACID ESTERS AND DICARBOXYLIC ACID DIESTERS BASF SE (DE) 2025-09-17 EP disclosed
EP-4596616-A2 PLASTICIZER COMPOSITION CONTAINING POLYMERIC DICARBOXYLIC ACID ESTERS AND DICARBOXYLIC ACID DIESTERS BASF SE (DE) 2025-08-06 EP disclosed
US-20250000088-A1 ANT CONTROL AGENT AND ANT CONTROL METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-01-02 US disclosed
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed
EP-0094456-B1 PREPARATION OF ALCOHOLS FROM OLEFINS HAVING FROM 3 TO 7 CARBON ATOMS MONSANTO COMPANY (US) 1986-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428364-B2 Method for processing benzene polycarboxylic acid esters and use of same to produce cyclohexane polycarboxylic acid esters DDT, HPD, DDC TSHR 4096/4885SMN1; SMN2 3913/4885LMNA 3771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.